Article info

Download PDFPDF
Extended report
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Authors

  1. Correspondence to Professor J E Gottenberg, Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, 1 Avenue Molière, 67000 Strasbourg, France; jacques-eric.gottenberg{at}chru-strasbourg.fr
View Full Text

Citation

Gottenberg JE, Ravaud P, Cantagrel A, et al
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Publication history

  • Accepted February 25, 2012
  • First published May 21, 2012.
Online issue publication 
May 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.